We observed that the frequency of CLEC10A+ CD1c+ cells was significantly lower in the FLT3-ITD+ AML group compared to HD and FLT3-WT AML (Figure 1H) and the same was true for the CLEC10A- cDC2s (Figure 1I). This evidence concerns the gene FLT3 and acute myeloid leukemia.